Custo-efetividade do tratamento da infecção pelo vírus da hepatite ...

92
HUSEREAU, D. et al. Interferon-based Therapies for Chronic Hepatitis C Virus
Infection: An Assessment of Clínical Outcomes. Canada: Canadian Coordinating Office
for Health Technology Assessment, 2004. 52 p.
IANHEZ, L. E. et al. Hepatopatia como causa de óbito pós-transplante renal. J. Bras. Nefrol.,
v. 19, n. 2, p. 138-42, Jun. 1997.
INSTITUTO BRASILEIRO DE GEOGRAFIA E ESTATÍSTICA. Projeção da População
do Brasil por sexo e idade: 1980-2050 - Revisão 2008. Disponível em:
. Acesso em: 28 dez. 2008.
INSTITUTO BRASILEIRO DE GEOGRAFIA E ESTATÍSTICA. Tábuas Completas de
Mortalidade - 2007. Disponível em:
. Acesso
em: 28 set. 2008.
KAMAR, N. et al. Treatment of hepatitis C virus infection (VHC) after renal transplantation:
implications for VHC-positive dialysis patients awaiting a kidney transplant.
Transplantation, v.82, n.7, p.853-856, Oct. 2006 a .
KASISKE, B.L. et al. Diabetes mellitus after kidney transplantation in the United States.
American Journal of Transplantation , v. 3, n. 2, p. 178-85 , Feb. 2003.
Kidney disease improving global outcomes (KDIGO): clínical practice guidelines for the
prevention, diagnosis, evaluation and treatment of hepatitis C in chronic kidney disease.
Kidney Int, v.73, sup. 109, p.S1–S99, Apr. 2008.
KOKOGLU, H. U. et al. Efficacy and tolerability of pegylated-interferon alpha-2a in
hemodialysis patients with chronic hepatitis C. Journal of Gastroenterology and
Hepatology, v. 21, n. 3, p. 575-80, Mar. 2006.
LÓPEZ-HIDALGO, R. et al. Association between diabetes mellitus and hepatitis C in kidney
transplant patients. Nefrologia, v. 24, n. 6, p. 572-8, Jan. 2004.
MORALES, J.M. et al. The influence of hepatitis B and hepatitis C virus infection in the
recipient on late renal allograft failure. Nephrol Dial Transplant, v. 19, sup. 3, p. 72-6, Jun.
2004 .
MORALES, J.M. et al. Membranous Glomerulonephritis Associated With Hepatitis C Virus
Infection In Renal Transplant Patients. Transplantation, v. 63, n. 11, p. 1634-1639, Jun.
1997.
MOUSA, D H et al. Alpha-interferon with ribavirin in the treatment of hemodialysis patients
with hepatitis C. Transplantation Proceedings, v. 36, n. 6, p. 1831-1834, 2004.
NATIONAL INSTITUTE FOR CLÍNICAL EXCELLENCE.(NICE) Interferon alfa
(pegylated and non-pegylated) and ribavirin for the treatment of chronic hepatitis C.
Technology Appraisal Guidance 75, England, 2004.
NATOV, S.N.; PEREIRA, B.J.G. Management of Hepatitis C Infection in Renal Transplant
Recipients. American Journal of Transplantation, v. 2, n.6, p. 483-90, Jul.2002.